The FSA Strides to Lead the Regulatory Approach to Caffeine

THE AFR CAFFEINE SERIES

The AFR Caffeine Series – Episode 2: A Long Time in Caffeine – a Decade since EFSA’s Scientific Opinion, we reviewed the findings and recommendations at that time – including the material upon which they were based.

In this, our third instalment of The AFR Caffeine Series – The UK Food Standards Agency makes strides to be the leading regulatory agency in its approach to Caffeine we will review the position adopted by the UK Food Standards Agency, as published in September 2024, now that they are free of the collective shackles of the European collective.

BREXIT AND A NEW-FOUND INDEPENDENCE FOR THE UK FOOD STANDARDS AGENCY

In March of this year we published a Paper identifying that the UK FSA WAS SEEKING TO PLOUGH ITS OWN FURROW AND SET ITSELF APART FROM ITS EUROPEAN COUNTERPARTS.

In what is perhaps the first manifestation of that sentiment, in September the Agency issued two sets of new guidance on caffeine in Food Supplements:

  • one to Consumers; and,
  • one to businesses who manufacture, process, distribute and/or sell Food Supplements containing caffeine.

While it is acknowledged that the UK Guidance relates to the use of caffeine in Food Supplements, rather than simply Foods, it is a notable departure from the “let’s see what EFSA do and then we will simply follow” approach – which had been feared as a “worst of all worlds and best of none” stasis policy that might have been adopted.

At AFR we commend to UK FSA for ploughing that independent furrow – of thought, mind and action – which, if it becomes a permanent mindset of the Agency, will bode well for the UK Food and Advanced Food industry.

UK FOOD STANDARDS AGENCY (UK FSA) GUIDANCE TO CONSUMERS CONCERNING CAFFEINE IN FOOD SUPPLEMENTS

Within the new Guidance the UK FSA advises consumers to be mindful of caffeine intake when using Food Supplements, cautioning that the caffeine intake from should products should be correlated alongside all other sources from within the general diet –such as coffee, tea, cocoa and energy drinks.

The Guidance repeats the 2015 EFSA Panel’s opinion (see The AFR Caffeine Series – Episode 2: A Long Time in Caffeine – a Decade since EFSA’s Scientific Opinion), that caffeine intakes of up to 400mg per day are unlikely to cause adverse effects in adults and recommending a limit of 200mg per day for those who are pregnant.

The Guidance has been created following a case in the UK where a man died after miscalculating the amount of caffeine powder he was meant to use, which resulted in his ingestion of a dose equivalent to 200 cups of coffee.

This correlated with the results of a survey which suggested that less than half of people spoken to indicated that it was their practice to look for dosage
instructions on Food Supplements (20% confessed that they don’t even read the label).

Research into consumer attitudes towards Food Supplements revealed that many consumers have limited or no knowledge as to the “background” presence of caffeine in Food Supplements and were only mindful of it when it was overtly publicised as an “active ingredient”.

It is the UK FSA’s opinion, reached in conjunction with other government departments who hold co-responsibility in respect of ingredients commonly found within such products, that at very high levels, caffeine can cause anxiety, sleeplessness, agitation, palpitations, diarrhoea and restlessness. Furthermore, individuals with a mental health condition can experience worsened psychosis and these effects may be more severe in individuals who are caffeine sensitive, or who have underlying health issues such as heart disease or high blood pressure.

The UK FSA position is that they are not seeking to over-regulate either caffeine or Food Supplements, but wish to draw consumers’ attention to the reality that caffeine overtly added to Food Supplements can often be at much higher levels than one would traditionally find in products in which it was an organic element (such as coffee) or in “traditional” energy drinks.

UK FOOD STANDARDS AGENCY (UK FSA) GUIDANCE TO BUSINESSES WHO MANUFACTURE, PROCESS, DISTRIBUTE AND/OR SELL FOOD SUPPLEMENTS CONTAINING CAFFEINE

The Guidance acknowledges that caffeine is a substance that is found naturally in many products and that it is one of the most widely consumed stimulants worldwide.

As a result they recognise that it is commonly added to Food Supplements, which are then marketed with physiological effects, such as increased focus and performance enhancement.

FORMS OF FOOD SUPPLEMENTS CONTAINING CAFFEINE

The UK FSA observe that caffeine is found in a variety of Food Supplements, including:

  • 100% caffeine powder – the most concentrated form of caffeine that can be found on the UK market;
  • caffeine supplements which contain caffeine and other ingredients and are sold dose in form;
  • food supplements in which caffeine is not specified in the name of the product, but is listed in the ingredients (for example, pre-workout supplements); and,
  • food supplements in which caffeine is not listed as an ingredient on the packaging but contains caffeine.

MANUFACTURERS AND BUSINESSES ARE OVERTLY REMINDED OF THE POTENTIAL SIDE EFFECTS FROM HIGH CAFFEINE INTAKE

Having re-affirmed the “existing” EFSA intake recommendations (i.e. those from 2015), the Agency but goes on to stress the potential side effects of high intake of caffeine and reminds businesses – in what one might term as a “passive, aggressive” manner which negates any ability for such businesses to later feign ignorance of the potential detrimental consequences of their failing in their duty to provide adequate information to their consumers – that:

  • individuals who are sensitive to caffeine at low doses and/or individuals with underlying health conditions may experience some side effects such as jitteriness, anxiety or difficulty concentrating;
  • short term adverse effects of an excessive consumption of caffeine in children and adults include interrupted sleep, anxiety and behavioural changes;
  • longer term consumption of excess caffeine has been linked to cardiovascular issues i.e. effects on the heart and blood vessels;
  • high exposure of caffeine is associated with increased tension, nervousness, anxiety, irritability, nausea, pins and needles sensation, tremor, – sweating, palpitations (racing irregular heartbeat), restlessness and possibly dizziness;
  • these effects may be more severe in individuals who are caffeine sensitive and/or have underlying health issues such as heart disease or high blood pressure, and effects may occur at lower doses;
  • excessive caffeine consumption is associated with a number of serious adverse effects such rapid heart rate, abnormal heart rhythms and seizures, which have been observed at intakes of approximately 1.2 grams (1,200 mg) of caffeine;
  • excessive consumption of caffeine during pregnancy has been associated with an increased risk of stunted foetus development;
  • caffeine intakes of above 10 – 14 grams (10,000 mg – 14,000 mg) have been reported to be fatal, although smaller doses can also be life-threatening to sensitive populations (although it is acknowledged that these cases have occurred where pure caffeine has been measured incorrectly).

MANUFACTURERS AND BUSINESSES ARE OVERTLY REMINDED OF THE LEGAL POSITION IN RESPECT OF THE USE OF CAFFEINE IN FOOD SUPPLEMENT PRODUCTS

The Agency acknowledges that in the UK there is no maximum legal limit for caffeine when used in Food Supplements but goes on to direct the businesses to find what constraints there are in respect of its use – again, in what one might term as a “passive, aggressive” manner which negates any ability for such businesses to later feign ignorance of the existence of limitations in respect of the use of the ingredient.

They draw specific attention to the fact that there are:

  • maximum permitted limits for caffeine set in legislation when used as a flavouring in certain foods or drinks found in assimilated Regulation (EC) No 1334/2008 .
  • specific labelling requirements for food and drink containing caffeine which can be found in Annex III of Regulation (EU) No 1169/2011 on the Provision of Food Information to Consumers.

In an overt reminder of the bastion of responsibility they remind businesses that:

  • it is the businesses’ responsibility to ensure Food Supplements it sells are safe for human consumption;
  • it is an offence under the Food Safety Act 1990 to render food injurious to health;
  • under the Food Safety Act 1990 food which fails to comply with food safety requirements may be seized and destroyed, at the expense of the food business operator; and,
  • the factors which determine whether food is “unsafe” or “injurious to health” are set out in article 14 of Regulation (EC) 178/2002.

PROPORTIONATE REGULATION – THE PROVISION OF ADVICE WHICH THEY EXPECT TO BE FOLLOWED

In what is perhaps another manifestation of their professed intention to “regulate proportionately”, the Agency sets out a set of seven principles that it expects businesses to abode by – and by which they will no doubt be judged in the event that their conduct in respect of potential consumer detriment is required to be assessed.

We reproduce those principles as stated in order to remove any nuance of interpretation.

  1. ENSURE YOU COMPLY WITH REGULATORY STANDARDS to protect consumers and maintain the reputation of your business. Failure to comply with applicable legislation can lead to legal repercussions and damage to your brand’s reputation.
  2. ENSURE THAT THE CAFFEINE USED IN YOUR PRODUCTS IS FROM REPUTABLE SUPPLIERS who are registered as a business with their local authority and provide fully referenced invoices and receipts.
  3. PROVIDE CLEAR DOSAGE GUIDANCE: Ambiguity or lack of clarity in dosage instructions may result in consumers misusing your products, leading to adverse health effects or dissatisfaction. Clearly communicate recommended serving sizes and precautions to minimise the risks.
  4. MAKE SURE YOU COMPLY WITH LEGAL LABELLING REQUIREMENTS: Ensure the caffeine dose stated on the label is accurate. EFSA’s 2015 opinion recommends ‘single doses of no more than 200mg per a single serving or over a total of 400mg a day’. Doses containing a higher recommended daily consumption level higher than 400 mg may lead to negative side effects.
  5. ENSURE ACCURACY OF PROVIDED MEASURING DEVICES: If you sell a powdered or liquid form of a supplement, make measuring dosages accessible and accurate to consumers by providing a measuring device such as a scoop. Inaccurate or unreliable measuring devices included with your supplements can compromise consumer safety and satisfaction. Conduct regular quality control checks to verify the precision of measuring instruments and provide adequate training for staff responsible for packaging to minimize errors.
  6. SHARE INFORMATION ONLINE RESPONSIBLY: While online platforms (i.e. websites, commercial apps, social media etc), can be valuable for marketing and customer engagement, disseminating inaccurate or misleading information about your products can damage trust and credibility. Ensure inaccurate or misleading information about your products can damage trust and credibility. Ensure that any information shared online is accurate, transparent, and compliant with regulations to maintain consumer confidence.
  7. ENCOURAGE CONSUMER ENGAGEMENT WITH HEALTHCARE PROFESSIONALS: Promote responsible usage of your supplements by advising consumers to seek guidance from healthcare professionals before starting any new dietary regimen. Emphasise the importance of informed decision-making and the potential risks associated with improper usage.

THE AFR CAFFEINE SERIES FINAL INSTALLMENT

In the final instalment of The AFR Caffeine Series – Episode 4: Who knows what the Future Brings? Matt and Steve will assess what the future might bring for caffeine as an ingredient and the Food and Food Supplement products in which it is either inherent or included as an active ingredient.

Remember what we always say: Foresight beats hindsight, at a fraction of the cost.

Georgios Pessios
Advanced Food Regulation